Connecticut 2022 2022 Regular Session

Connecticut Senate Bill SB00186 Introduced / Fiscal Note

Filed 04/27/2022

                    OFFICE OF FISCAL ANALYSIS 
Legislative Office Building, Room 5200 
Hartford, CT 06106  (860) 240-0200 
http://www.cga.ct.gov/ofa 
sSB-186 
AN ACT CONCERNING COLLABORATIVE DRUG THERAPY 
MANAGEMENT AGREEMENTS AND POLICIES. 
AMENDMENT 
LCO No.: 5642 
File Copy No.: 213 
Senate Calendar No.: 169  
 
Primary Analyst: ME 	4/27/22 
Contributing Analyst(s):  	() 
 
 
 
 
OFA Fiscal Note 
 
State Impact: 
Agency Affected Fund-Effect FY 23 $ FY 24 $ 
Consumer Protection, Dept. GF - Cost 96,668 96,668 
State Comptroller - Fringe 
Benefits
1
 
GF - Cost 36,646 36,646 
Resources of the General Fund GF - Revenue 
Impact 
See Below See Below 
Note: GF=General Fund  
Municipal Impact: None  
Explanation 
The amendment strikes the underlying bill and its associated fiscal 
impact resulting in the following impact.  
The amendment allows the creation of collaborative drug therapy 
management policies and agreements between prescribing practitioners 
and pharmacists resulting in a cost to the Department of Consumer 
Protection (DCP) and the Office of the State Comptroller beginning in 
FY 24.  DCP will have to hire one drug control agent for a total cost
2
 of 
$135,564 in FY 24 to review the collaborative drug therapy agreements 
 
1
The fringe benefit costs for most state employees are budgeted centrally in accounts 
administered by the Comptroller. The estimated active employee fringe benefit cost 
associated with most personnel changes is 40.53% of payroll in FY 23. 
2
 Total cost includes salary, other expenses, and fringe benefits.  2022SB-00186-R00LCO05642-FNA.DOCX 	Page 2 of 2 
 
 
and enforce the expanded scope of practice for pharmacists. 
The amendment also changes the pharmacist license expiration date 
from biennially to annually and changes the fee from $120 every two 
years to $100 every year resulting in a revenue gain to the state over a 
two-year period. 
The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely 
for the purposes of information, summarization and explanation and does not represent the intent of the General 
Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of 
informational sources, including the analyst’s professional knowledge. Whenever applicable, agency data is 
consulted as part of the analysis, however final products do not necessarily reflect an assessment from any 
specific department.